1. Andriole V. Use of quinolones in treatm ent of prostatitis and lower urinary tract infections / / Eur.J.Clin.Microbiol.Infect.Dis.- 1991.- Vol. 10.- P. 342- 350.
2. Cox C.E. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin for treatm ent of serious urinary tract infections / / Am .J.Med.- 1992.- Vol. 92, № 6 .- Suppl.4A .- P. 82 S- 86 S.
3. Fass R .J. Efficacy and safety of oral ciprofloxacin for treatm ent of serious urinary tract infections / / Antimicrob. Agents Chcm other.- 1987.- Vol. 3 1 .- P. 148- 150.
4. Mcint T.G.K. Multiple-dose pharm acokinetics of lomefloxacin: rationale for once-a-day dosing / / Am .J.M ed.- 1992.- Vol. 92, № 6 .- Suppl.4 A .- P. 26 S- 32 S.
5. Naber K .G., Baurnfeind A ., Diellein G., Wittenberger R . Urinary tract infections in elderly urological patients / / New Trendsin Urinarv Tract Infections / Ed. H.C .Neu , J.D .Williams.- Basel: Kargcr, 1988.- P. 48- 61.
6. . Nea H .C. Quinolones: a new class of antimicrobial with wide potential uses / / Med.Clin.North Am.- 1988.- Vol. 7 2 .- P. 623- 626.
7. Neu H.C . Urinary tract infections / / Am .J.Med.- 1992.- Vol. 92, № 6 .- Suppl.4A .- P. 63 S- 70 S.
8. . Siporin C. The evalution of the fluorinated quinolons: pharm acology, microbiological activity, clinical uses, toxicises / / Ann.Rev.Microbiol.- 1989.- Vol. 4 3 .- P. 601- 627.
9. Wise R ., Andrews J .M ., Ash ly J .P ., Motthews R .S . In vitro activity of lom efloxacin, a new quinolone antimicrobial agentin comparison to those of other agents / / Antimicrob.Agents Chemother.- 1988.- Vol. 3 2 .- P. 617- 622.
10. Wordwordth A .N ., Goa K.L. Lomefloxacin: a review of its antim icrobial activity, pharm acokinetic properties and therapeutic use / / Drugs.- 1991.- Vol. 42, № 6 .- P. 1018- 1060.